SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹75 Cr | ₹35 Cr | ₹36 Cr | ₹34 Cr | ₹28 Cr |
What is the latest Total Liabilities ratio of SHUKRA PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹75 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹36 Cr |
Mar2020 | ₹34 Cr |
Mar2019 | ₹28 Cr |
How is Total Liabilities of SHUKRA PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹75 Cr | 113.50 | |
Mar2022 | ₹35 Cr | -1.39 | |
Mar2021 | ₹36 Cr | 6.15 | |
Mar2020 | ₹34 Cr | 18.16 | |
Mar2019 | ₹28 Cr | - |
Compare Total Liabilities of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹487.5 Cr | -7.8% | 23.9% | 531.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | -7.8% |
23.9% |
531.6% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses